HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
HSR 609
structure in first source
Also Known As:
HSR-609
Networked:
2
relevant articles (
1
outcomes,
1
trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Pyridines: 88
HSR 609: 2
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Benzoxepins: 1
HSR 609: 2
Experts
1.
Musoh, K
: 2 articles (11/2000 - 08/2000)
2.
Nagai, H
: 2 articles (11/2000 - 08/2000)
3.
Nakamura, N
: 1 article (11/2000)
4.
Inagaki, N
: 1 article (08/2000)
5.
Maeda, Y
: 1 article (08/2000)
6.
Tanaka, H
: 1 article (08/2000)
Related Diseases
1.
Eosinophilia
11/01/2000 - "
Effects of an amphoteric antiallergic agent, HSR-609, on antigen-induced late phase nasal eosinophilia in brown Norway rats.
"
08/01/2000 - "
At the same time HSR-609 inhibited the antigen-induced eosinophilia and IL-5 production in BALF.
"
11/01/2000 - "
These results suggest that this late phase eosinophilia model in the nose of BN rats may be useful for investigating the therapeutic drugs for nasal allergy and a newly synthesized amphoteric antiallergic agent, HSR-609, may be useful for the treatment of allergic rhinitis with eosinophilia.
"
08/01/2000 - "
These results suggest that HSR-609 inhibits allergic airway hyperresponsiveness to acetylcholine probably because of the inhibition of Th2-dependent eosinophilia caused by IL-5.
"
11/01/2000 - "
In the second part of the study, the effects of prednisolone, cetirizine and a newly synthesized amphoteric antiallergic agent, HSR-609, on this allergic late nasal eosinophilia and neutrophilia in BN rats were investigated.
"
2.
Allergic Rhinitis
11/01/2000 - "
These results suggest that this late phase eosinophilia model in the nose of BN rats may be useful for investigating the therapeutic drugs for nasal allergy and a newly synthesized amphoteric antiallergic agent, HSR-609, may be useful for the treatment of allergic rhinitis with eosinophilia.
"
3.
Hypersensitivity (Allergy)
11/01/2000 - "
These results suggest that this late phase eosinophilia model in the nose of BN rats may be useful for investigating the therapeutic drugs for nasal allergy and a newly synthesized amphoteric antiallergic agent, HSR-609, may be useful for the treatment of allergic rhinitis with eosinophilia.
"
4.
Rhinitis
11/01/2000 - "
The effect of a newly synthesized compound, HSR-609, on rat experimental rhinitis was investigated.
"
5.
Respiratory Hypersensitivity
08/01/2000 - "
The effects of a newly synthesized anti-allergic agent, HSR-609, on allergic airway hyperresponsiveness and airway inflammation have been studied in sensitized mice.
"
08/01/2000 - "
Effect of a novel anti-allergic agent, HSR-609, on antigen-induced airway hyperresponsiveness in mice.
"
08/01/2000 - "
These results suggest that HSR-609 inhibits allergic airway hyperresponsiveness to acetylcholine probably because of the inhibition of Th2-dependent eosinophilia caused by IL-5.
"
08/01/2000 - "
In addition, effects of HSR-609 were different from those of cetirizine and terfenadine concerning the inhibition of antigen-induced airway hyperresponsiveness in mice.
"
08/01/2000 - "
HSR-609 (10 mg/kg) and prednisolone (5 mg/kg) significantly inhibited the antigen-induced airway hyperresponsiveness, whereas cetirizine (10 mg/kg) or terfenadine (100 mg/kg) did not affect this airway response.
"
Related Drugs and Biologics
1.
Anti-Allergic Agents (Antiallergic Agents)
2.
Cetirizine (Zyrtec)
3.
Prednisolone (Predate)
4.
Antigens
5.
Terfenadine (Seldane)
6.
Interleukin-5 (Interleukin 5)
7.
Acetylcholine (Acetylcholine Chloride)